Autism Symposium

Zelda Therapeutics was proud to sponsor the Medical Marijuana and Autism Consensus Symposium on 19 October 2019 in Philadelphia, bringing together leading experts in Autism to discuss the potential benefits of medicinal cannabis.

Results from the Observational Study for autism being undertaken in collaboration with the Children’s Hospital of Philadelphia were presented at the conference.  Preliminary data has shown that treatment with medicinal cannabis can be associated with improved behavioural outcomes in autistic children.

The videos below are of the speakers from the Autism Symposium, which include:

Dr. Rachel Levine

Overview of Pennsylvania Medical Marijuana Program

Dr. Benjamin Yerys

Overview of ASD Symptoms Targeted for Treatment
Current Pharmacologic Treatment Approaches to ASD, Risks and Benefits, Successes and Failures

Dr. Dustin Sulak 

Summary of Preclinical and Clinical Trials (Observational and Clinical) for Autism Medical Cannabis and ASD Plus Other Indications. How/Where Do We Target Future Research Efforts?

Dr. Bonni Goldstein
Experiences in Treating ASD Patients with Medical Cannabis

Dr. Athena Zuppa
Summary of Key Outcomes to CHOP Observational Trial. Current Utilization in ASD (CHOP Study) to include PK Information

Dr. Doris Trauner
Update on Current CBD and Autism Trial

Dr. Meghan Thomas
What is Australia Doing? Zelda-sponsored Phase I/II ASD Clinical Trial

Panel Discussion 

{Lead by Dr. F. Xavier Castellanos}
Dr. Doris Trauner & Dr. Athena Zuppa
Can Collaboration Help Us Transcend Regulatory and Research Challenges? Who's on First?

Research Study Parent Session

Dr. Benjamin Yerys
Overview of CHOP Study and Presentation of General Interim Results to include Disease Burden of Children with ASD, Dosing Variability, Dosing Patterns and Dose Related to Efficacy (Educational Component)

Dr. Rachel Levine - Overview of Pennsylvania Medical Marijuana Program
19/10/2019

Dr. Benjamin Yerys - Overview of CHOP Study and Presentation of General Interim Results
19/10/2019

Dr. Dustin Sulak - Summary of Preclinical and Clinical Trials for Autism Medical Cannabis and ASD
19/10/2019

Dr. Bonni Goldstein - Experiences in Treating ASD Patients with Medical Cannabis
19/10/2019

Dr. Athena Zuppa - Summary of Key Outcomes to CHOP Observational Trial
19/10/2019

Dr. Doris Trauner - Update on Current CBD and Autism Trial
19/10/2019

Dr. Meghan Thomas - What is Australia Doing? Zelda-sponsored Phase I/II ASD Clinical Trial
19/10/2019

Panel Discussion - Can Collaboration Help Us Transcend Regulatory and Research Challenges? Who's on First?
19/10/2019

Dr. Athena Zuppa - Summary of Key Outcomes to CHOP Observational Trial
19/10/2019